Cameron Duncan
Psychiatric/Mental Health · Reno, NVNPI 1629372800
Payments from drug & device makers
Across 143 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$222
- Takeda Pharmaceuticals U.S.A., Inc.$172
- Indivior Inc.$150
- Otsuka America Pharmaceutical, Inc.$148
- Johnson & Johnson$140
- plus $695 from 16 others
What the payments were for
- Food & beverage$2,64298%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $1,163 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $172 |
| Indivior Inc. | 5 | $150 |
| Otsuka America Pharmaceutical, Inc. | 9 | $148 |
| Johnson & Johnson | 2 | $140 |
| Lucid Diagnostics Inc. | 1 | $113 |
| Sunovion Pharmaceuticals Inc. | 5 | $106 |
| Neurocrine Biosciences, Inc. | 4 | $73 |
| Supernus Pharmaceuticals, Inc. | 5 | $70 |
| Eisai Inc. | 4 | $65 |
| Amgen | 2 | $50 |
| Corium, LLC | 4 | $45 |
| Alkermes, Inc. | 2 | $34 |
| Pfizer | 2 | $25 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Lundbeck LLC | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$125
How this compares
$2,689 in reported general payments places this provider in the 80th percentile of 362 psychiatric/mental health providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 13 | $493 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Reno
- Okechukwu OlisaReno$7K
- Kaiwen JiangReno$6K
- Alana RogneReno$6K
- Doris AnukamReno$5K
- Megan SeivertReno$4K
- Denis WilliamsReno$4K
- Nathanael MellumReno$3K
- Jacqueline WilliamsReno$3K
- Michelle GiddingsLas Vegas$131K
- Patrick ApiladoLas Vegas$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.